ArticleBMC cancer2020

Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development.

Jennifer S Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.